Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Sep;128(1-2):21-8.
doi: 10.1016/j.jviromet.2005.03.021.

Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins

Ralph A Tripp  1 , Lia M Haynes, Deborah Moore, Barbara Anderson, Azaibi Tamin, Brian H Harcourt, Les P Jones, Mamadi Yilla, Gregory J Babcock, Thomas Greenough, Donna M Ambrosino, Rene Alvarez, Justin Callaway, Sheana Cavitt, Kurt Kamrud, Harold Alterson, Jonathan Smith, Jennifer L Harcourt, Congrong Miao, Raj Razdan, James A Comer, Pierre E Rollin, Thomas G Ksiazek, Anthony Sanchez, Paul A Rota, William J Bellini, Larry J Anderson
Affiliations

Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins

Ralph A Tripp et al. J Virol Methods. 2005 Sep.

Abstract

Monoclonal antibodies (Mabs) against the Urbani strain of the SARS-associated coronavirus (SARS-CoV) were developed and characterized for reactivity to SARS-CoV and SARS-CoV S, N, M, and E proteins using enzyme-linked immunoabsorbent (ELISA), radioimmunoprecipitation, immunofluorescence, Western Blot and microneutralization assays. Twenty-six mAbs were reactive to SARS-CoV by ELISA, and nine were chosen for detailed characterization. Five mAbs reacted against the S protein, two against the M protein, and one each against the N and E proteins. Two of five S protein mAbs neutralized SARS-CoV infection of Vero E6 cells and reacted to an epitope within amino acids 490-510 in the S protein. While two of the three non-neutralizing antibodies recognized at second epitope within amino acids 270-350. The mAbs characterized should prove useful for developing SARS-CoV diagnostic assays and for studying the biology of infection and pathogenesis of disease.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Immunofluorescence staining (IFA) of SARS-CoV infected Vero E6 cells. A representative IFA is shown for an S protein-specific mAb (mAb 341) and M protein-specific mAb (mAb 292). Cell staining was visualized at 40× and 100× using a Zeiss Axioskop microscope with an Axiovert BlueH 485 nm filter and an RT Color Spot digital camera.
Fig. 2
Fig. 2
Radioimmunoprecipitation of mAbs with SARS-CoV lysate. SARS-CoV-infected Vero E6 cells (+) or mock-infected Vero E6 cells (−) were radiolabeled with [35S]-methionine/cysteine and reacted with individual mAbs to determine antigen specificity as described previously in Section 2. The anti-SARS-CoV S (S) mAbs (341, 534, 560, and 240) detected a protein with an apparent molecular mass of approximately 150 kDa, while the anti-matrix (M, 283) and anti-nucleocapsid (N, 42) mAbs detected proteins with an apparent molecular mass of approximately 25 kDa and 45 kDa, respectively. No bands were detected in the uninfected Vero E6 lysate control. The lack of signal with mAb 154 is likely due to the differential binding properties of protein G.
Fig. 3
Fig. 3
Schematic diagram of the various S glycoprotein fragments synthesized. The top box represents the whole length of SARS-CoV S glycoprotein (aa 1–1255) and the relative sizes of the selected S protein fragments are shown.
Fig. 4
Fig. 4
Epitope mapping of neutralizing and non-neutralizing anti-S mAbs. The epitopes recognized by the anti-S protein mAbs were determined by Western Blot with C-terminally truncated S proteins covering the region between amino acids 269 and 1190 of the S protein. S1190, aa 1–1190; S510, aa 1–510; S490, aa 1–490; S350, aa 1–350; S270–510, aa 270–510; S269, aa 1–269. A representative Western Blot for a neutralizing anti-S protein monoclonal, 341C (A), a non-neutralizing anti-S protein monoclonal, 560C (B), SARS convalescent-phase sera (C) and anti-(His)6 antibody (D) are shown.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Babcock G.J., Esshaki D.J., Thomas W.D., Jr., Ambrosino D.M. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor. J. Virol. 2004;78:4552–4560. - PMC - PubMed
    1. Benaroch P., Yilla M., Raposo G., Ito K., Miwa K., Geuze H.J., Ploegh H.L. MHC class II molecules reach the endocytic pathway. EMBO J. 1995;14:37–49. - PMC - PubMed
    1. Berry J.D., Jones S., Drebot M.A., Andonov A., Sabara M., Yuan X.Y., Weingartl H., Fernando L., Marszal P., Gren J., Nicolas B., Andonova M., Ranada F., Gubbins M.J., Blake Ball T., Kitching P., Li Y., Kabani A., Plummer F. Development and characterization of neutralising monoclonal antibody to the SARS-coronavirus. J. Virol. Methods. 2004;120:87–96. - PMC - PubMed
    1. Che X.Y., Hao W., Qiu L.W., Pan Y.X., Liao Z.Y., Xu H., Chen J.J., Hou J.L., Woo P.C., Lau S.K., Kwok Y.Y., Huang Z. Antibody response of patients with severe acute respiratory syndrome (SARS) to nucleocapsid antigen of SARS-associated coronavirus. Di Yi Jun Yi Da Xue Xue Bao. 2003;23:637–639. - PubMed
    1. Daniel C., Talbot P.J. Protection from lethal coronavirus infection by affinity-purified spike glycoprotein of murine hepatitis virus, strain A59. Virology. 1990;174:87–94. - PMC - PubMed

Publication types

MeSH terms